All In MedTech

Device Trial Radar · NCT06680427

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

Last checked: Nov 20, 2026Latest source record: Dec 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Mar 26, 2025

Primary completion

Dec 2025

Study completion Dec 2025

Sponsor

Lead sponsor
MiRusNot on our public-company list
Sponsor type
Industry
First posted
Nov 8, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Siegel™ Transcatheter Aortic Valve (TAVR) early feasibility study objective is to assess the acute and long-term safety and feasibility of the Siegel TAVR device in adult subjects with symptomatic, severe native aortic stenosis eligible for the transcatheter aortic valve replacement.

Conditions

  • Aortic Stenosis Symptomatic

Interventions

  • Siegel Transcatheter Aortic Valve (TAVR)Device

    Replacement of native aortic valve with the Siegel Transcatheter Aortic Valve (TAVR) by a transfemoral approach.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical success of implantation of the Siegel TAVRTime frame: Immediate post procedure
  2. All-cause mortality or disabling strokeTime frame: 30 Days

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Stanford

    Palo Alto, California

  • NCH Healthcare System

    Naples, Florida

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.